Top

Published in:

01-08-2018 | Original Research

“Second-Class Status?” Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome

Authors: Alexandra Suttman, Robert Pilarski, Doreen M. Agnese, Leigha Senter

Published in: Journal of Genetic Counseling | Issue 4/2018

Abstract

Hereditary breast and ovarian cancer syndrome (HBOC) is a cancer predisposition syndrome that affects both men and women, with more significant cancer risk elevations in women. Dissemination patterns regarding familial genetic risk information among females with HBOC are fairly well defined, but knowledge about how males share this information is limited. We interviewed 21 people primarily Ashkenazi Jewish men who were accrued via listserv email through Facing Our Risk of Cancer Empowered (FORCE). Interviews focused on family cancer history, experiences with cancer and genetic testing, motivations to pursue genetic testing and subsequently disclose genetic test results, information-sharing patterns, health care provider response, and participants’ emotional support systems. The interviews were transcribed in their entirety, coded, and analyzed based on recurring themes. Eighteen transcripts were used for the analysis. Results were classified into five main themes. Participants (n = 8) were most concerned about cancer risk for their children and female family members, and most (n = 11) mentioned that HBOC provides them increased personal awareness, but has a negligible impact on their life overall (n = 9). Men (n = 11) were interested in a male-focused support group to discuss HBOC and gain knowledge and information. Participants (n = 9) took on active and open communication roles with family members and health care providers. The majority of participants (n = 14) discussed the need for knowledge and awareness among the health care community and general population regarding male HBOC risks. This study serves as a pilot study and provides important and novel insights into psychosocial impacts, communication patterns, encounters with health care professionals, and expressed needs of males with HBOC.

d’Agincourt-Canning, L. (2001). Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics, 15(3), 231–247.CrossRefPubMed

Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D. M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjakoski, K., Kallioniemi, O. P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D. G., & Easton, D. F. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), 1117–1130.CrossRefPubMedPubMedCentral

Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.CrossRef

Cheng, H. H., Pritchard, C. C., Montgomery, B., Lin, D. W., & Nelson, P. S. (2017). Prostate cancer screening in a new era of genetics. Clinical Genitourinary Cancer, 15(6), 625–628.

Cheung, E. L., Olson, A. D., Yu, T. M., Han, P. Z., & Beattie, M. S. (2010). Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiology, Biomarkers, & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(9), 2211–2219.CrossRef

Dancyger, C., Wiseman, M., Jacobs, C., Smith, J. A., Wallace, M., & Michie, S. (2011). Communicating BRCA1/2 genetic test results within the family: a qualitative analysis. Psychology & Health, 26(8), 1018–1035.CrossRef

Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., Armstrong, K., Rebbeck, T. R., & Domchek, S. M. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–91.CrossRefPubMedPubMedCentral

Gadzicki, D., Wingen, L. U., Teige, B., Horn, D., Bosse, K., Kreuz, F., Goecke, T., Schafer, D., Voigtlander, T., Fischer, B., Froster, U., Welling, B., Debatin, I., Weber, B. H., Schonbuchner, I., Nippert, I., Schlegelberger, B., & German Cancer Aid Consortium on Hereditary Breast and Ovarian Cancer. (2006). Communicating BRCA1 and BRCA2 genetic test results. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(18), 2969–2970 author reply 2970-1.CrossRef

Graves, K. D., Gatammah, R., Peshkin, B. N., Krieger, A., Gell, C., Valdimarsdottir, H. B., & Schwartz, M. D. (2011). BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Familial Cancer, 10(2), 213–223.CrossRefPubMedPubMedCentral

Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., & Watson, M. (2005). Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clinical Genetics, 67(6), 492–502.CrossRefPubMed

Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., Lynch, H. T., & Narod, S. A. (2000). Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67(6), 1494–1504.CrossRefPubMedPubMedCentral

Liede, A., Karlan, B. Y., & Narod, S. A. (2004). Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22(4), 735–742.CrossRef

Ormond, K. E., Mills, P. L., Lester, L. A., & Ross, L. F. (2003). Effect of family history on disclosure patterns of cystic fibrosis carrier status. American Journal of Medical Genetics, Part C, Seminars in Medical Genetics, 119C(1), 70–77.CrossRef

Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(4), 700–706.CrossRef

Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., & Gritz, E. R. (2003). How families communicate about HNPCC genetic testing: Findings from a qualitative study. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 119C(1), 78–86.CrossRefPubMed

Shiloh, S., Dagan, E., Friedman, I., Blank, N., & Friedman, E. (2013). A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes. Psycho-Oncology, 22(2), 417–425.PubMed

Stromsvik, N., Raheim, M., Oyen, N., & Gjengedal, E. (2009). Men in the women’s world of hereditary breast and ovarian cancer—a systematic review. Familial Cancer, 8(3), 221–229.CrossRefPubMed

Stromsvik, N., Raheim, M., & Gjengedal, E. (2011). Cancer worry among Norwegian male BRCA1/2 mutation carriers. Familial Cancer, 10(3), 597–603.CrossRefPubMedPubMedCentral

Vadaparampil, S. T., Malo, T., de la Cruz, C., & Christie, J. (2012). Do breast cancer patients tested in the oncology care setting share BRCA mutation results with family members and health care providers? Journal of Cancer Epidemiology, 2012, 498062.CrossRefPubMedPubMedCentral

Wiseman, M., Dancyger, C., & Michie, S. (2010). Communicating genetic risk information within families: a review. Familial Cancer, 9(4), 691–703.CrossRefPubMed

Wymer, P. (1996). The troubled helix: social and psychological implications of the new human genetics. In T. Marteau & M. Richards (Eds.), Cambridge University Press. Trends in Biochemical Sciences, 21(10), 404.

Title: “Second-Class Status?” Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome
Authors: Alexandra Suttman
Robert Pilarski
Doreen M. Agnese
Leigha Senter
Publication date: 01-08-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 4/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-018-0214-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

“Second-Class Status?” Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women

Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer

Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress

High-Risk Palliative Care Patients’ Knowledge and Attitudes about Hereditary Cancer Testing and DNA Banking

“Bridge to the Literature”? Third-Party Genetic Interpretation Tools and the Views of Tool Developers

Genesurance Counseling: Patient Perspectives